Email This Article

Headlines & Perspectives
Bristol-Myers to Buy Rights to Hep C Drug
By Adam Feuerstein
01/12/09 - 04:21 PM EST
Bristol-Myers has agreed to pay $85 million upfront to ZymoGenetics for rights to PEG-Interferon lambda and will pay another $20 million license fee to ZymoGenetics in 2009, the companies announced Monday.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,226.94 1,093.07 2,154.06 34.86
Oil *
77.65
UP
203.52
UP
23.77
UP
41.62
DOWN
0.17
10 Yr
3.49%
SPDR Gold
108.19
+2.03%
+2.22%
+1.97%
-0.49%
Data delayed 20 minutes

Brokerage Partners